Lifestyle treatment for patients with morbid obesity
The Effect of Lifestyle Treatment on Physical Capacity, Maximal Strength, Eating Behavior and Quality of Life in Patients With Morbid Obesity
This study tests if a special lifestyle program can help people with morbid obesity lose weight and improve their quality of life compared to an older treatment method.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Sykehuset i Vestfold HF Academic / other |
| Locations | 1 site (Tønsberg) |
| Trial ID | NCT03593148 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of an intensive lifestyle treatment program on weight loss and health-related quality of life in patients with morbid obesity. It compares the outcomes of this program to a previous treatment approach, focusing on improvements in physical capacity, leg strength, and eating behavior. The study also examines whether patients with better physical and bone strength before treatment experience greater weight loss over time. Participants will undergo a structured intervention over several months to assess these outcomes.
Who should consider this trial
Good fit: Ideal candidates are treatment-seeking individuals with a BMI of 40 kg/m2 or higher, or 35 to 39.9 kg/m2 with at least one comorbidity.
Not a fit: Patients with severe heart conditions, recent cardiovascular events, or severe eating disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve weight loss and quality of life for patients with morbid obesity.
How similar studies have performed: Previous studies have shown positive outcomes with lifestyle interventions for obesity, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Treatment seeking morbidly obese patients (BMI ≥ 40 kg/m2 or BMI 35 to 39.9 kg/m2 with ≥ 1 co morbidity) attending the Vestfold Hospital Trust. Exclusion Criteria: * Uncompensated heart failure * Recent myocardial infarction or stroke (\<½ years) * Severe arrhythmia or heart failure * Unstable angina pectoris * Renal failure * Pregnancy * Severe eating disorders * Active substance abuse
Where this trial is running
Tønsberg
- Jarle Berge — Tønsberg, Norway (Recruiting)
Study contacts
- Principal investigator: Jens Hertel, PhD — The Hospital of Vestfold
- Study coordinator: Jarle Berge
- Email: jarle.berge@siv.no
- Phone: +47 33134111
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.